Work

Lenalidomide (Revlimid®) for the first-line therapy of transplant-ineligible patients with multiple myeloma

Year: 2012

Type: article

Authors: C. Poggiani, A. Nachtnebel

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W87448443

FWCI:

Cites:

Cited by:

Related to: 10